This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (42)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

FRANK W. HARTMAN, M.D.

AMA Arch Surg. 1951;63(6):728-738.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

RENEWED interest in plasma substitutes or plasma extenders and emergency substances has been brought about by the apparently successful production and use of dextran and polyvinylpyrrolidone abroad, the favorable impression made by their trial here, as outlined in the previous communication, and most important, the definite need for supplies of this type which may be stock-piled in large quantities for indefinite periods against major disasters.

It is now well established that certain exogenous as well as endogenous macromolecular colloids are capable of increasing and maintaining blood volume by means of their osmotic pressure, hydrophilic properties and slow elimination from the vascular system. It is the purpose of this communication to evaluate the pathologic tissue changes resulting from the introduction of these colloids rather than their physiologic effects or their effectiveness in shock and dehydration. As outlined by Hueper¹ and others,² the four exogenous macromolecular substances now most available . . . [Full Text PDF of this Article]

Author Affiliations
DETROIT

Footnotes
Read before the Section on Anesthesiology as part of a symposium on Plasma Volume Expanders in the Treatment of Shock at the One-Hundredth Annual Session of the American Medical Association, Atlantic City, June 13, 1951.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?